Mark A. Behlke
Direttore Tecnico/Scientifico/R&S presso Integrated DNA Technologies, Inc.
Profilo
Mark A.
Behlke is the founder of Dicerna Pharmaceuticals, Inc. which was founded in 2007.
He is currently the Chief Scientific Officer at Integrated DNA Technologies, Inc. Dr. Behlke has a doctorate degree from Washington University in St. Louis which he received in 1988 and an undergraduate degree from Massachusetts Institute of Technology which he received in 1981.
Posizioni attive di Mark A. Behlke
| Società | Posizione | Inizio |
|---|---|---|
Integrated DNA Technologies, Inc.
 Integrated DNA Technologies, Inc. Chemicals: SpecialtyProcess Industries Integrated DNA Technologies, Inc. manufactures nucleic acid products. It specializes in DNA synthesis, gene construction, antisense oligos, molecular beacons, and a variety of molecular biology products. The company was founded by Joseph A. Walder in 1987 and is headquartered in Skokie, IL. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Mark A. Behlke
| Società | Posizione | Fine |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Fondatore | - |
Formazione di Mark A. Behlke
| Massachusetts Institute of Technology | Undergraduate Degree |
| Washington University in St. Louis | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Integrated DNA Technologies, Inc.
Integrated DNA Technologies, Inc. Chemicals: SpecialtyProcess Industries Integrated DNA Technologies, Inc. manufactures nucleic acid products. It specializes in DNA synthesis, gene construction, antisense oligos, molecular beacons, and a variety of molecular biology products. The company was founded by Joseph A. Walder in 1987 and is headquartered in Skokie, IL. | Process Industries |
- Borsa valori
- Insiders
- Mark A. Behlke